nach oben

Erschienen in:

01.08.2008 | Rapid Communication

Association of Asthma Self-efficacy to Asthma Control and Quality of Life

verfasst von: Kim L. Lavoie, Ph.D., Anne Bouchard, B.Sc., Maryann Joseph, B.A., Tavis S. Campbell, Ph.D., Helene Favreau, B.Sc., Simon L. Bacon, Ph.D.

Erschienen in: Annals of Behavioral Medicine | Ausgabe 1/2008

Einloggen, um Zugang zu erhalten

Abstract

Background

Achieving optimal asthma control relies upon several behavioral factors (self-monitoring, treatment adherence) that may be influenced by asthma self-efficacy (ASE).

Purpose

To assess the extent to which levels of ASE are associated with asthma control and asthma-related quality of life in patients with asthma.

Methods

A total of 557 adult patients with documented asthma completed a battery of questionnaires (Asthma Self-Efficacy Scale, ASES; Asthma Control Questionnaire, ACQ; Asthma Quality of Life Questionnaire, AQLQ) and standard spirometry. Patients also underwent a sociodemographic, medical history, and psychiatric interview. Partial correlations adjusting for covariates were conducted to assess associations between ASES scores and ACQ and AQLQ scores.

Results

Results indicated that ASES scores were negatively correlated with ACQ total score and individual items scores, indicating that higher levels of ASE were associated with improved asthma control, and positively correlated with AQLQ total and subscale scores, indicating that higher levels of ASE were associated with better asthma-related quality of life. All findings were independent of covariates.

Conclusions

Findings suggest that being confident in one’s ability to control asthma symptoms is associated with better asthma control and quality of life. Future studies should assess the direction of the association between self-efficacy and asthma morbidity in order to determine optimal treatment targets.

Global Initiative for Asthma. Global strategy for asthma management and prevention. NIH Publication No 02-3659; 2005.

Chapman KR, Boulet LP, FitzGerald MJ, McIvor RA, Zimmerman S. Patient factors associated with suboptimal asthma control in Canada: Results from the reality of asthma control study. Am J Respir Crit Care Med. 2005; 172: A678.

Bateman ED, Boushey HA, Bousquet J, et al. Can guideline-defined asthma control be achieved? The gaining optimal asthma control study. Am J Respir Crit Care Med. 2004; 170(8): 836–844.PubMedCrossRef

Tobin DL, Wigal JK, Winder JA, Holroyd KA, Creer TL. The “Asthma Self-Efficacy Scale”. Ann Allergy. 1987; 59(4): 273–277.PubMed

Bandura A. Self-efficacy: Toward a unifying theory of behavioral change. Psychol Rev. 1977; 84: 191–215.PubMedCrossRef

van Es SM, Kaptein AA, Bezemer PD, et al. Predicting adherence to prophylactic medication in adolescents with asthma: An application of the ASE-model. Patient Educ Couns. 2002; 47(2): 165–171.PubMedCrossRef

Scherer YK, Bruce S. Knowledge, attitudes, and self-efficacy and compliance with medical regimen, number of emergency department visits, and hospitalizations in adults with asthma. Heart Lung. 2001; 30(4): 250–257.PubMedCrossRef

Mancuso CA, Rincon M, McCulloch CE, Charlson ME. Self-efficacy, depressive symptoms, and patients’ expectations predict outcomes in asthma. Med Care. 2001; 39(12): 1326–1338.PubMedCrossRef

Hesselink AE, Penninx BWJH, Schlosser MAG, Wijnhoven HAH, van der Windt DAWM, Kriegsman DMW, et al. The role of coping resources and coping style in quality of life of patients with asthma or COPD. Qual Life Res. 2004; 13: 509–518.PubMedCrossRef

10.

American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med. 1995; 152(3): 1107–1136.

11.

Lavoie KL, Cartier A, Labrecque M, Bacon SL, Lemiere C, Malo JL, et al. Are psychiatric disorders associated with worse asthma control and quality of life in asthma patients? Respir Med. 2005; 99(10): 1249–1257.PubMedCrossRef

12.

Aboussafy D, Campbell TS, Lavoie K, Aboud FE, Ditto B. Airflow and autonomic responses to stress and relaxation in asthma: The impact of stressor type. Int J Psychophysiol. 2005; 57(3): 195–201.PubMedCrossRef

13.

Campbell TS, Lavoie KL, Bacon SL, et al. Asthma self-efficacy, high frequency heart rate variability, and airflow obstruction during negative affect in daily life. Int J Psychophysiol. 2006; 62: 109–114.PubMedCrossRef

14.

Juniper EF, O’Byrne PM, Guyatt GH, Ferrie PJ, King DR. Development and validation of a questionnaire to measure asthma control. Eur Respir J. 1999; 14(4): 902–907.PubMedCrossRef

15.

Juniper EF, Bousquet J, Abetz L, Bateman ED, The Goal Committee. Identifying ‘well-controlled’ and ‘not well-controlled’ asthma using the Asthma Control Questionnaire. Respir Med. 2006; 100: 616–621.PubMedCrossRef

16.

Schatz M, Sorkness CA, Li JT, Marcus P, Murray JJ, Nathan RA, et al. Asthma control test: Reliability, validity, and responsiveness in patients not previously followed by asthma specialists. J Allergy Clin Immunol. 2006; 117(3): 549.PubMedCrossRef

17.

Juniper EF. Asthma-related quality of life. 2005 [cited 2005 September 22, 2005]; Available from: http://www.qoltech.co.uk/language_lists.html#aqlq.

18.

Juniper EF, Guyatt GH, Ferrie PJ, Griffith LE. Measuring quality of life in asthma. Am Rev Respir Dis. 1993; 147(4): 832–838.PubMed

19.

Leidy NK, Coughlin C. Psychometric performance of the asthma quality of life questionnaire in a US sample. Qual Life Res. 1998; 7(2): 127–134.PubMedCrossRef

20.

Spitzer RL, Williams JB, Kroenke K, Linzer M, deGruy FV 3rd, Hahn SR, et al. Utility of a new procedure for diagnosing mental disorders in primary care. The PRIME-MD 1000 Study. J Am Med Assoc. 1994; 272(22): 1749–1756.CrossRef

21.

Goodwin RD, Olfson M, Shea S, et al. Asthma and mental disorders in primary care. Gen Hosp Psych. 2003; 25(6): 479–483.CrossRef

22.

Goldney RD, Ruffin R, Fisher LJ, Wilson DH. Asthma symptoms associated with depression and lower quality of life: A population survey. Med J Aust. 2003; 178(9): 437–441.PubMed

23.

Lavoie KL, Bacon SL, Labrecque M, Cartier A, Ditto B. Higher BMI is associated with worse asthma control and quality of life but not asthma severity. Respir Med. 2006; 100: 648–657.PubMedCrossRef

24.

Altman DG, Schulz KF, Moher D, Group. ftC. The revised CONSORT statement for reporting randomized trials: Explanation and elaboration. Ann Intern Med. 2001; 134: 663–694.PubMed

25.

Freedland KE, Babyak MA, McMahon RJ, et al. Statistical guidelines for psychosomatic medicine. Psychosom Med. 2005; 67(2): 167.CrossRef

26.

Teixeira PJ, Going SB, Sardinha LB, Lohman TG. A review of psychosocial pre-treatment predictors of weight control. Obes Rev. 2005; 6(1): 43–65.PubMedCrossRef

27.

Ronmark E, Andersson C, Nystrom L, et al. Obesity increases the risk of incident asthma among adults. Eur Respir J. 2005; 25(2): 282–288.PubMedCrossRef

28.

Chinn S. Concurrent trends in asthma and obesity. Thorax. 2005; 60(1): 3–4.PubMedCrossRef

29.

Ludman E, Katon W, Bush T, et al. Behavioural factors associated with symptom outcomes in a primary care-based depression prevention intervention trial. Psychol Med. 2003; 33(6): 1061–1070.PubMedCrossRef

30.

Katon WJ, Richardson L, Lozano P, McCauley E. The relationship of asthma and anxiety disorders. Psychosom Med. 2004; 66(3): 349–355.PubMedCrossRef

31.

Gibson PC, Caughlan J, Wilson AJ, et al. Limited (information-only) asthma education on health outcomes of adults with asthma. Oxford, England: Cochrane Library; 2001.

32.

Put C, van den Bergh O, Lemaigre V, Demedts M, Verleden G. Evaluation of an individualised asthma programme directed at behavioural change. Eur Respir J. 2003; 21(1): 109–115.PubMedCrossRef

33.

van der Palen J, Klein JJ, Zielhuis GA, Van Herwaarden CLA, Seydel E. Behavioral effect of self-management guidelines in a self-management program for adults with asthma. Patient Educ Couns. 2001; 43: 161–169.PubMedCrossRef

Titel: Association of Asthma Self-efficacy to Asthma Control and Quality of Life
verfasst von: Kim L. Lavoie, Ph.D.
Anne Bouchard, B.Sc.
Maryann Joseph, B.A.
Tavis S. Campbell, Ph.D.
Helene Favreau, B.Sc.
Simon L. Bacon, Ph.D.
Publikationsdatum: 01.08.2008
Verlag: Springer-Verlag
Erschienen in: Annals of Behavioral Medicine / Ausgabe 1/2008
Print ISSN: 0883-6612
Elektronische ISSN: 1532-4796
DOI: https://doi.org/10.1007/s12160-008-9053-8

Neu in den Fachgebieten Neurologie und Psychiatrie

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Delir bei kritisch Kranken – Antipsychotika versus Placebo

16.05.2024 Delir Nachrichten

Um die Langzeitfolgen eines Delirs bei kritisch Kranken zu mildern, wird vielerorts auf eine Akuttherapie mit Antipsychotika gesetzt. Eine US-amerikanische Forschungsgruppe äußert jetzt erhebliche Vorbehalte gegen dieses Vorgehen. Denn es gibt neue Daten zum Langzeiteffekt von Haloperidol bzw. Ziprasidon versus Placebo.

Schwindelursache: Massagepistole lässt Otholiten tanzen

14.05.2024 Benigner Lagerungsschwindel Nachrichten

Wenn jüngere Menschen über ständig rezidivierenden Lagerungsschwindel klagen, könnte eine Massagepistole der Auslöser sein. In JAMA Otolaryngology warnt ein Team vor der Anwendung hochpotenter Geräte im Bereich des Nackens.

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Association of Asthma Self-efficacy to Asthma Control and Quality of Life